We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$41.6B
AUM Growth
+$4.19B
Cap. Flow
+$2.15B
Cap. Flow %
5.18%
Top 10 Hldgs %
17.44%
Holding
1,483
New
402
Increased
470
Reduced
298
Closed
268

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$493M
2
WBA
Walgreens Boots Alliance
WBA
+$361M
3
V icon
Visa
V
+$291M
4
CRM icon
Salesforce
CRM
+$278M
5
STZ icon
Constellation Brands
STZ
+$254M

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 17.07%
3 Financials 14.54%
4 Consumer Discretionary 11.34%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAY
301
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$20.7M 0.05%
1,090,557
+641,601
+143% +$12M
CUBE icon
302
CubeSmart
CUBE
$9.5B
$20.6M 0.05%
+713,933
New +$19.9M
LNW
303
DELISTED
Light & Wonder
LNW
$20.6M 0.05%
401,899
-49,378
-11% -$2.41M
APH icon
304
Amphenol
APH
$212B
$20.5M 0.05%
935,284
-3,357,312
-78% -$73.9M
SLAB icon
305
Silicon Laboratories
SLAB
$7.2B
$20.4M 0.05%
231,146
-86,523
-27% -$7.77M
QVCGA
306
DELISTED
QVC Group Inc Series A
QVCGA
$20.2M 0.05%
+17,076
New +$19.8M
HLF icon
307
Herbalife
HLF
$1.31B
$20.1M 0.05%
+592,416
New +$20.8M
DAN icon
308
Dana Inc
DAN
$3.01B
$19.9M 0.05%
623,028
+581,092
+1,386% +$17.9M
GLW icon
309
Corning
GLW
$135B
$19.8M 0.05%
+619,900
New +$19.5M
CNA icon
310
CNA Financial
CNA
$14.2B
$19.8M 0.05%
373,588
+196,288
+111% +$10.3M
AVGO icon
311
Broadcom
AVGO
$1.99T
$19.6M 0.05%
764,220
+731,220
+2,216% +$19M
WPP icon
312
WPP
WPP
$4.45B
$19.6M 0.05%
216,667
-63,122
-23% -$5.59M
AGR
313
DELISTED
Avangrid, Inc.
AGR
$19.4M 0.05%
383,808
+146,158
+62% +$7.39M
HBM icon
314
Hudbay
HBM
$11.5B
$18.9M 0.05%
2,144,616
+875,870
+69% +$6.83M
BCC icon
315
Boise Cascade
BCC
$2.98B
$18.9M 0.05%
474,415
+347,123
+273% +$12.9M
FTV icon
316
Fortive
FTV
$18.5B
$18.8M 0.05%
411,952
-872,072
-68% -$39.9M
TPR icon
317
Tapestry
TPR
$32.2B
$18.7M 0.05%
423,233
+90,233
+27% +$3.72M
GIL icon
318
Gildan
GIL
$10.8B
$18.7M 0.04%
578,805
+537,205
+1,291% +$16.8M
BC icon
319
Brunswick
BC
$5.43B
$18.6M 0.04%
337,700
+276,100
+448% +$15M
KRO icon
320
KRONOS Worldwide
KRO
$714M
$18.5M 0.04%
719,527
+68,013
+10% +$1.78M
AVY icon
321
Avery Dennison
AVY
$13.4B
$18.5M 0.04%
160,697
+88,842
+124% +$9.6M
AZTA icon
322
Azenta
AZTA
$1.47B
$18.4M 0.04%
771,244
+393,416
+104% +$11.2M
KLIC icon
323
Kulicke & Soffa
KLIC
$4.91B
$18.3M 0.04%
753,386
PRLB icon
324
Protolabs
PRLB
$2.16B
$18.1M 0.04%
175,884
+150,222
+585% +$13.5M
POST icon
325
Post Holdings
POST
$4.04B
$18.1M 0.04%
+349,301
New +$18.6M

Similar funds

Arrowstreet Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Arrowstreet Capital held 1,483 positions worth $41.6B, up 11% from $37.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Arrowstreet Capital deployed $2.15B of net new capital in Q4 2017, opening 402 new positions and adding to 470 existing holdings. Its largest new stake was Charter Communications: 357,363 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $1.01B trimmed.

  • Arrowstreet Capital's largest Q4 2017 buy was Charter Communications: 357,363 shares worth $120M.
  • Arrowstreet Capital added most to CVS Health in Q4 2017, an estimated $493M increase.
  • Arrowstreet Capital's biggest Q4 2017 reduction was Amazon, cutting an estimated $1.01B.
  • Arrowstreet Capital fully exited American International in Q4 2017, selling an estimated $285M.
  • Arrowstreet Capital's ten largest holdings make up 17% of its $41.6B portfolio in Q4 2017.
  • Arrowstreet Capital opened 402 new positions and closed 268 in Q4 2017.
  • Arrowstreet Capital's portfolio value rose 11% quarter-over-quarter to $41.6B.

Based on Arrowstreet Capital's 13F filing for Q4 2017, filed 9 Feb 2018.